The NLRP3 inflammasome has been shown to promote immune evasion in pancreatic cancer, specifically by differentiating T cells into pro-tumor populations (Th2, Th17, and T regs) and preventing the activation of tumor-killing CD8+ T cells (12). This evidence concerns the gene NLRP3 and familial pancreatic carcinoma.